“Use of Biological Disease-Modifying Antirheumatic Drugs (bDMARD) Therapy in Rheumatoid Arthritis: A Review of Side Effects and Immunological Mechanisms: English”, AMJEL, vol. 1, no. 5, pp. 16–22, Nov. 2024, doi: 10.70471/y4mv8218.